Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Gross Profit (2016 - 2025)

Historic Gross Profit for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $2.9 million.

  • Nephros' Gross Profit rose 3564.45% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year increase of 3712.66%. This contributed to the annual value of $8.7 million for FY2024, which is 378.35% up from last year.
  • Nephros' Gross Profit amounted to $2.9 million in Q3 2025, which was up 3564.45% from $2.8 million recorded in Q2 2025.
  • Nephros' 5-year Gross Profit high stood at $3.2 million for Q1 2025, and its period low was $762000.0 during Q3 2022.
  • Moreover, its 5-year median value for Gross Profit was $2.0 million (2023), whereas its average is $1.9 million.
  • As far as peak fluctuations go, Nephros' Gross Profit tumbled by 4397.06% in 2022, and later skyrocketed by 18792.65% in 2023.
  • Quarter analysis of 5 years shows Nephros' Gross Profit stood at $1.5 million in 2021, then increased by 2.58% to $1.5 million in 2022, then surged by 33.93% to $2.0 million in 2023, then rose by 22.46% to $2.5 million in 2024, then rose by 17.78% to $2.9 million in 2025.
  • Its Gross Profit stands at $2.9 million for Q3 2025, versus $2.8 million for Q2 2025 and $3.2 million for Q1 2025.